Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US before and during the Delta Variant Surge

Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US before and during the Delta Variant Surge

Importance: Vaccination against the SARS-CoV-2 virus is critical to control the pandemic. Randomized clinical trials demonstrated efficacy of the single-dose Ad26.COV2.S COVID-19 vaccine, but data on longer-term protection in clinical practice and effectiveness against variants are needed. Objective...

Full description

Bibliographic Details
Main Authors: Batech, M. (Author), Harvey, R. (Author), Jain, S. (Author), Kabelac, C. (Author), Kamath, T. (Author), Khan, N. (Author), Polinski, J.M (Author), Rassen, J.A (Author), Schneeweiss, S. (Author), Weckstein, A.R (Author)
Format: Article
Language:English
Published: American Medical Association 2022
Subjects:
Ad26COVS1
adolescent
Adolescent
adult
Adult
aged
Aged
cohort analysis
Cohort Studies
COVID-19
diagnosis
epidemiology
female
Female
hospitalization
Hospitalization
human
Humans
incidence
Incidence
male
Male
middle aged
Middle Aged
prevention and control
propensity score
Propensity Score
SARS-CoV-2
United States
vaccine
Vaccine Efficacy
young adult
Young Adult
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items